Effectiveness of cognitive behavioral therapy on the signs, symptoms and clinical consequences of premature ejaculation

Mohammadi, Seyyed Davoud; Mohammadkhani, Parvaneh; Dolatshahi, Behruz; Dadkhah, Asghar

doi:10.1111/jpr.12020

Cited by 6 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After removing 1736 papers through the title/abstract screening, 91 were retrieved as full text. Of the 91 full text, 36 studies were excluded because they were theoretical, opinion, focused on erectile dysfunction or included only pharmacological treatments, leaving 54 studies to be included in the systematic review 14–67 …”

Section: Resultsmentioning

confidence: 99%

Non‐pharmacological approaches for treatment of premature ejaculation: a systematic review

Pizzol¹,

Sánchez

Ilie

et al. 2023

Trends Urol & Men's Health

View full text Add to dashboard Cite

Premature ejaculation is a common male condition worldwide with prevalence estimates varying from 30% to 85%. Owing to the lack of a clear definition and a clear understanding of the potentially multifactorial pathophysiology, treatment remains challenging. The aim of this systematic review was to evaluate the non‐pharmacological treatment modalities for PE to inform clinical practice and patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Non‐pharmacological approaches for treatment of premature ejaculation: a systematic review

Pizzol¹,

Sánchez

Ilie

et al. 2023

Trends Urol & Men's Health

View full text Add to dashboard Cite

show abstract

“…The validated Persian versions of the following tools, measures, and questionnaires were used in this study: demographic characteristics questionnaire based on ISAP (INCAS Substance Abuse Profile) ( 23 ), drugs use history, current treatment characteristics checklist, duration of treatment, agonist dose, International Index of Erectile Function (IIEF) [Cronbach's alpha values = 0.91 and 0.73 in original and adjusted Persian versions, respectively] ( 24 , 25 ); Index of Premature Ejaculation (IPE) [Cronbach's alpha values = 0.85 and 0.98 in original and adjusted Persian versions, respectively] ( 26 , 27 ); Beck Depression Inventory (BDI) ) [Cronbach's alpha values = 0.73 and 0.87 in the original beck and adjusted Persian versions, respectively] ( 28 , 29 ), and Beck Anxiety Inventory (BAI) [Cronbach's alpha values = 0.92 and 0.92 in the original beck and adjusted Persian versions, respectively] ( 30 , 31 ).…”

Section: Methodsmentioning

confidence: 99%

Comparing Sexual Function between Opioid Dependents Consuming Methadone or Opium Tincture

Moeeni¹,

Sisakht²,

Vousooghi³

et al. 2021

IJPS

View full text Add to dashboard Cite

Objective: Sexual dysfunction is a side effect of methadone maintenance therapy (MMT). Opium Tincture (OT) has been used as a maintenance treatment. This study aimed to determine and compare the trend of sexual function and its related factors during treatment with both drugs. Method: An observational study was designed to measure the blood tests including free and total testosterone, prolactin, and sex hormone-binding globulin and a battery of questionnaires, including demographics and drug use history, in 42 and 53 patients entering MMT and OT treatment before and 1 and 3 months after the treatment. Results: Significant changes in testosterone levels were observed in the MMT but not the OT group. The difference between the two groups was not significant. Neither between nor within changes in the sexual function and premature ejaculation scores were significant (P =0.370& 0.698). Anxiety levels were significantly different (P= 0.001) within and between groups. There was a considerable difference in the trend of depression changes in the OT group, but not different in MMT group and between the two groups. Conclusion: No difference was found between MMT and OT effects on sexual function variables. The decrease in Testosterone during the three months of MMT, was not associated with diminished sexual function. In the MMT group, anxiety levels diminished during treatment. It seems that decreased testosterone in the MMT group was compensated by improved anxiety. Gonadotropin levels may not be the sole determinant in sexual activity, and complex interaction of mood and anxiety, agonist levels, and gonadotropins are involved.

show abstract

“…For example, female sexual desire, arousal, orgasm, and sexual pain disorders; as well as male premature ejaculation, erectile dysfunction, and delayed ejaculation have been found to respond to cognitive-behavioral and mindfulness therapies (Andersson et al, 2011; Brotto, Basson & Luria, 2008; Brotto, Basson, Smith, Driscoll & Sadownik, 2015; Brotto & Smith, 2014; Brotto, Woo & Leiblum, 2010; Frühauf, Gerger, Schmidt, Munder & Barth, 2013; Jones & McCabe, 2011; Mohammadi, Mohammadkhani, Dolatshahi & Dadkhah, 2013). This is not conclusive evidence, as cognitive-behavioral therapy (CBT) covers a broad variety of therapeutic techniques that can be effective for most mental disorders.…”

Section: Part 2: Evidence That Supports the Formation Of The Hypothesmentioning

confidence: 99%

A Place for Sexual Dysfunctions in an Empirical Taxonomy of Psychopathology

Forbes

Baillie

Eaton

et al. 2017

The Journal of Sex Research

View full text Add to dashboard Cite

Sexual dysfunctions commonly co-occur with various depressive and anxiety disorders. An emerging framework for understanding the classification of mental disorders suggests that such comorbidity is a manifestation of underlying dimensions of psychopathology (or “spectra”). In this review, we synthesize the evidence that sexual dysfunctions should be included in the empirical taxonomy of psychopathology as part of the internalizing spectrum, which accounts for comorbidity among the depressive and anxiety disorders. The review has four parts. Part 1 summarizes the empirical basis and utility of the empirical taxonomy of psychopathology. Part 2 reviews the prima facie evidence for the hypothesis that sexual dysfunctions are part of the internalizing spectrum (i.e., high rates of comorbidity; shared cognitive, affective, and temperament characteristics; common neural substrates and biomarkers; shared course and treatment response; and the lack of causal relationships between them). Part 3 critically analyzes and integrates the results of the eight studies that have addressed this hypothesis. Finally, Part 4 examines the implications of reconceptualizing sexual dysfunctions as part of the internalizing spectrum, and explores avenues for future research.

show abstract

Effectiveness of cognitive behavioral therapy on the signs, symptoms and clinical consequences of premature ejaculation

Cited by 6 publications

References 31 publications

Non‐pharmacological approaches for treatment of premature ejaculation: a systematic review

Non‐pharmacological approaches for treatment of premature ejaculation: a systematic review

Comparing Sexual Function between Opioid Dependents Consuming Methadone or Opium Tincture

A Place for Sexual Dysfunctions in an Empirical Taxonomy of Psychopathology

Contact Info

Product

Resources

About